Holen Sie sich die Stockscreener-App
0.2684
6.38%
-0.0137
Schlusskurs vom Vortag:
$0.282
Offen:
$0.2764
24-Stunden-Volumen:
312.40K
Relative Volume:
0.04
Marktkapitalisierung:
$11.40M
Einnahmen:
$20.27M
Nettoeinkommen (Verlust:
$-63.80M
KGV:
-0.1765
EPS:
-1.52
Netto-Cashflow:
$-68.35M
1W Leistung:
-6.71%
1M Leistung:
+16.92%
6M Leistung:
-34.02%
1J Leistung:
-72.93%
1-Tages-Spanne:
$0.255
$0.2915
1-Wochen-Bereich:
$0.25
$0.3075
52-Wochen-Spanne:
$0.1417
$1.27
Carisma Therapeutics Inc Stock (CARM) Company Profile
Firmenname
Carisma Therapeutics Inc
Sektor
Branche
Telefon
(267) 491-6422
Adresse
3675 MARKET STREET, PHILADELPHIA
Vergleichen Sie CARM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CARM
Carisma Therapeutics Inc
|
0.2728 | 11.86M | 20.27M | -63.80M | -68.35M | -1.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.90 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.00 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
455.22 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
717.64 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
331.36 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-04-11 | Eingeleitet | BTIG Research | Buy |
| 2023-10-03 | Eingeleitet | CapitalOne | Overweight |
| 2023-07-06 | Eingeleitet | Evercore ISI | Outperform |
| 2023-05-31 | Hochstufung | Jefferies | Hold → Buy |
| 2023-05-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-14 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Carisma Therapeutics Inc Aktie (CARM) Neueste Nachrichten
Chart overlay techniques for tracking Carisma Therapeutics Inc.CEO Change & Verified Technical Signals - newser.com
Should you wait for a breakout in Carisma Therapeutics Inc.Weekly Investment Recap & Smart Swing Trading Alerts - newser.com
Philly’s Carisma Therapeutics slashed its workforce to 6 from 46 for sale or wind down - MSN
What MACD signals say about Carisma Therapeutics Inc.July 2025 PostEarnings & Real-Time Volume Trigger Notifications - newser.com
How sentiment analysis helps forecast Carisma Therapeutics Inc.Earnings Performance Report & Stepwise Entry and Exit Trade Signals - newser.com
Macro Review: Is now the right time to enter Carisma Therapeutics IncPortfolio Gains Summary & Low Risk Growth Stock Ideas - خودرو بانک
Rate Cut: Will WeRide Inc Depositary Receipt benefit from sector rotationJuly 2025 Gainers & AI Driven Stock Movement Reports - khodrobank.com
Aug Sectors: What hedge funds are buying Carisma Therapeutics IncWeekly Stock Recap & Verified Chart Pattern Signals - khodrobank.com
Long term hold vs stop loss in Carisma Therapeutics Inc.2025 AllTime Highs & Technical Analysis for Trade Confirmation - newser.com
Ocugen Faces Merger Termination with Carisma Therapeutics - MSN
Comparing Carisma Therapeutics Inc. in custom built stock radarsWeekly Gains Summary & Community Verified Swing Trade Signals - newser.com
Earnings visualization tools for Carisma Therapeutics Inc.Swing Trade & Fast Gain Stock Tips - newser.com
Risk adjusted return profile for Carisma Therapeutics Inc. analyzed2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - newser.com
Backtesting results for Carisma Therapeutics Inc. trading strategiesExit Point & Intraday High Probability Setup Alerts - newser.com
Aug Movers: Can Carisma Therapeutics Inc lead its sector in growthQuarterly Trade Review & Daily Volume Surge Signals - خودرو بانک
What indicators show strength in Carisma Therapeutics Inc.Market Growth Report & Low Drawdown Momentum Trade Ideas - newser.com
Carisma Therapeutics Amends Agreement with Moderna - TipRanks
Can Carisma Therapeutics Inc. recover in the next quarterJuly 2025 Closing Moves & Free Safe Entry Trade Signal Reports - newser.com
Ocugen Enters Subscription Agreement with Carisma Therapeutics - MSN
Ocugen merger agreement with Carisma terminated due to funding shortfall - Investing.com
Growth Value: Can Carisma Therapeutics Inc. continue delivering strong returnsWeekly Investment Summary & Long-Term Safe Return Strategies - خودرو بانک
Carisma Therapeutics & Modernatx amend collaboration and license agreementSEC filing - MarketScreener
How to manage a losing position in Carisma Therapeutics Inc.2025 Biggest Moves & Short-Term Trading Alerts - newser.com
Can Carisma Therapeutics Inc. lead its sector in growth2025 Dividend Review & Technical Entry and Exit Tips - خودرو بانک
CEO Moves: Is Carisma Therapeutics Inc stock overvalued or fairly pricedPortfolio Gains Report & Weekly High Return Stock Opportunities - خودرو بانک
Using AI based signals to follow Carisma Therapeutics Inc.Weekly Investment Summary & High Conviction Buy Zone Alerts - newser.com
ETF Watch: What is the PEG ratio of Carisma Therapeutics IncQuarterly Portfolio Summary & Technical Buy Zone Confirmation - خودرو بانک
Levels Update: What’s the outlook for Carisma Therapeutics Inc.’s sectorRecession Risk & Risk Controlled Swing Alerts - خودرو بانک
Options Flow: What is Carisma Therapeutics Inc. s 5 year growth outlook2025 Performance Recap & Free Technical Pattern Based Buy Signals - خودرو بانک
Volume Recap: Can Carisma Therapeutics Inc lead its sector in growth2025 Momentum Check & Free Technical Confirmation Trade Alerts - خودرو بانک
Is Carisma Therapeutics Inc a speculative investmentWeekly Stock Analysis & Community Consensus Trade Alerts - خودرو بانک
Investment Review: Can Carisma Therapeutics Inc. continue delivering strong returnsPortfolio Value Report & Safe Capital Growth Stock Tips - خودرو بانک
Trend Report: Is Carisma Therapeutics Inc forming a bullish divergence2025 Big Picture & Capital Protection Trade Alerts - خودرو بانک
Aug Drivers: Is Carisma Therapeutics Inc a speculative investment2025 Macro Impact & AI Powered Market Entry Ideas - khodrobank.com
OrthoCellix cancelled the acquisition of Carisma Therapeutics, Inc. from group of shareholders in a reverse merger transaction. - MarketScreener
Quarterly Recap: What’s the outlook for Carisma Therapeutics Inc.’s sectorEarnings Trend Report & Reliable Price Breakout Alerts - خودرو بانک
Reversal indicators forming on Carisma Therapeutics Inc. stockJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Finanzdaten der Carisma Therapeutics Inc-Aktie (CARM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):